Alphabet's Google is working on a new initiative to make its artificial intelligence chips better at running PyTorch, the ...
广受欢迎的人工智能代码编辑器开发商Cursor已完成23亿美元的后期投资,估值达到293亿美元。 Accel和Coatue领投了这轮D轮融资,Google、Nvidia、Thrive、Andreessen Horowitz和DST等公司参与跟投。Cursor在今天的融资公告中披露,其年化收入最近突破了10亿美元。 该公司注册名 ...
What’s the biggest capital commitment in Big Tech right now? AI infrastructure—and Google is shoveling cash into it faster than anyone expected. Just how quickly has Google’s capital spending ...
Google is reportedly planning to reduce Nvidia’s dominance in AI hardware. The company is said to be working with Meta to ...
ET BrandEquity on MSN
Google works to erode Nvidia's software advantage with Meta's help
Google launches 'TorchTPU' initiative to enhance TPU compatibility with PyTorch, aiming to rival Nvidia's GPU market lead with Meta's collaboration.
Nvidia lost billions of dollars from its market value after a report claimed that Meta, the parent company of Facebook and ...
Meta is in talks to shift part of its AI infrastructure to Google-made chips, instead of ones made by Nvidia, in a deal worth billions of dollars that could permanently upend the world of tech.
Cryptopolitan on MSN
Nvidia, Valeo reach settlement in trade secrets dispute tied to stolen autonomous‑driving ...
Nvidia settled a case that started when a former hire walked into the company with autonomous-driving trade secrets he had ...
13 天on MSN
Google teams up with Meta to challenge Nvidia's dominance in AI computing market — here's ...
Google is enhancing its AI chips to improve compatibility with PyTorch, aiming to challenge Nvidia's dominance in the AI computing market.
The venture capital arms of Nvidia and Google have backed Swedish startup Lovable in a $330 million Series B round that values the vibe coding platform at $6.6 billion. The investment triples ...
Shares in chipmaker Nvidia sank about 4% Tuesday following a report that Meta is in talks to spend billions of dollars on chips from rival Google. As part of the deal, Meta – the social media giant ...
In the pharma industry, when a generic drug wins approval, it creates a structural market shift. Being therapeutically equivalent to the branded drug, but 80–85% cheaper, generics quickly capture ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果